title: Consultation-liaison psychiatry drug--drug interactions update.
authors.affiliation: Willmar Regional Treatment Center, Minnesota 56201, USA. scott.armstrong@state.mn.us
authors.forename: S C
authors.initials: SC
authors.lastname: Armstrong
authors.forename: K L
authors.initials: KL
authors.lastname: Cozza
authors.forename: M A
authors.initials: MA
authors.lastname: Cole
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D020117:Cisapride / Q000009:adverse effects*; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004347:Drug Interactions; D004790:Enzyme Induction; D041743:Herb-Drug Interactions; D006801:Humans; D020902:Hypericum / Q000009:adverse effects*; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D010946:Plants, Medicinal; D011358:Product Surveillance, Postmarketing; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012017:Referral and Consultation
chemical_list: D000897:Anti-Ulcer Agents; D011619:Psychotropic Drugs; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D020117:Cisapride